Liquid biopsies: the future of cancer early detection

S Connal, JM Cameron, A Sala, PM Brennan… - Journal of translational …, 2023 - Springer
Cancer is a worldwide pandemic. The burden it imposes grows steadily on a global scale
causing emotional, physical, and financial strains on individuals, families, and health care …

Current advance of nanotechnology in diagnosis and treatment for malignant tumors

B Wang, S Hu, Y Teng, J Chen, H Wang, Y Xu… - … and Targeted Therapy, 2024 - nature.com
Cancer remains a significant risk to human health. Nanomedicine is a new multidisciplinary
field that is garnering a lot of interest and investigation. Nanomedicine shows great potential …

Global, regional, and national lifetime risks of develo** and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of …

S Wang, R Zheng, J Li, H Zeng, L Li, R Chen… - The Lancet …, 2024 - thelancet.com
Background Gastrointestinal cancers account for a quarter of the global cancer incidence
and a third of cancer-related deaths. We sought to estimate the lifetime risks of develo** …

Addressing cancer care inequities in sub-Saharan Africa: current challenges and proposed solutions

O Omotoso, JO Teibo, FA Atiba, T Oladimeji… - International journal for …, 2023 - Springer
Introduction Cancer is a significant public health challenge globally, with nearly 2000 lives
lost daily in Africa alone. Without adequate measures, mortality rates are likely to increase …

[HTML][HTML] The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC)

R Farghadani, R Naidu - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Breast cancer is a leadingcause of cancer-related deaths in women globally, with triple-
negative breast cancer (TNBC) being an aggressive subtype that lacks targeted therapies …

Harnessing the power of clinical decision support systems: challenges and opportunities

Z Chen, N Liang, H Zhang, H Li, Y Yang, X Zong… - Open …, 2023 - openheart.bmj.com
Clinical decision support systems (CDSSs) are increasingly integrated into healthcare
settings to improve patient outcomes, reduce medical errors and enhance clinical efficiency …

[HTML][HTML] Breast cancer in Asia: incidence, mortality, early detection, mammography programs, and risk-based screening initiatives

YX Lim, ZL Lim, PJ Ho, J Li - Cancers, 2022 - mdpi.com
Simple Summary Nearly all breast cancer patients survive for more than five years when the
tumor is found early and in the localized stage. Regular clinical breast examinations …

European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission

M Lawler, L Davies, S Oberst, K Oliver… - The Lancet …, 2023 - thelancet.com
Cancer research is a crucial pillar for countries to deliver more affordable, higher quality,
and more equitable cancer care. Patients treated in research-active hospitals have better …

Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments

SA McIntosh, F Alam, L Adams, IS Boon… - The Lancet …, 2023 - thelancet.com
Background Cancer is a leading cause of disease burden globally, with more than 19· 3
million cases and 10 million deaths recorded in 2020. Research is crucial to understanding …

Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwide

C Are, SS Murthy, R Sullivan, M Schissel… - The Lancet …, 2023 - thelancet.com
Summary The first Lancet Oncology Commission on Global Cancer Surgery was published
in 2015 and serves as a landmark paper in the field of cancer surgery. The Commission …